vs

Side-by-side financial comparison of Charles River Laboratories (CRL) and Snap-on (SNA). Click either name above to swap in a different company.

Snap-on is the larger business by last-quarter revenue ($1.2B vs $995.8M, roughly 1.2× Charles River Laboratories). Snap-on runs the higher net margin — 21.3% vs -1.5%, a 22.8% gap on every dollar of revenue. On growth, Snap-on posted the faster year-over-year revenue change (2.7% vs 1.2%). Over the past eight quarters, Snap-on's revenue compounded faster (2.0% CAGR vs -1.5%).

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

Snap-on Incorporated is an American designer, manufacturer, and marketer of high-end tools and equipment for professional use in the transportation industry, including the automotive, heavy duty, equipment, marine, aviation, and railroad industries. Headquartered in Kenosha, Wisconsin, since 1930, Snap-on also distributes lower-end tools under the brand name Blue-Point. Their primary competitors include Matco, Mac Tools, and Cornwell Tools.

CRL vs SNA — Head-to-Head

Bigger by revenue
SNA
SNA
1.2× larger
SNA
$1.2B
$995.8M
CRL
Growing faster (revenue YoY)
SNA
SNA
+1.5% gap
SNA
2.7%
1.2%
CRL
Higher net margin
SNA
SNA
22.8% more per $
SNA
21.3%
-1.5%
CRL
Faster 2-yr revenue CAGR
SNA
SNA
Annualised
SNA
2.0%
-1.5%
CRL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CRL
CRL
SNA
SNA
Revenue
$995.8M
$1.2B
Net Profit
$-14.8M
$260.7M
Gross Margin
Operating Margin
12.0%
27.8%
Net Margin
-1.5%
21.3%
Revenue YoY
1.2%
2.7%
Net Profit YoY
-157.2%
1.0%
EPS (diluted)
$-0.30
$4.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRL
CRL
SNA
SNA
Q1 26
$995.8M
Q4 25
$994.2M
$1.2B
Q3 25
$1.0B
$1.2B
Q2 25
$1.0B
$1.2B
Q1 25
$984.2M
$1.1B
Q4 24
$1.0B
$1.2B
Q3 24
$1.0B
$1.1B
Q2 24
$1.0B
$1.2B
Net Profit
CRL
CRL
SNA
SNA
Q1 26
$-14.8M
Q4 25
$-276.6M
$260.7M
Q3 25
$54.4M
$265.4M
Q2 25
$52.3M
$250.3M
Q1 25
$25.5M
$240.5M
Q4 24
$-214.5M
$258.1M
Q3 24
$69.7M
$251.1M
Q2 24
$94.1M
$271.2M
Gross Margin
CRL
CRL
SNA
SNA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
34.6%
Q2 24
34.5%
Operating Margin
CRL
CRL
SNA
SNA
Q1 26
12.0%
Q4 25
-28.5%
27.8%
Q3 25
13.3%
29.4%
Q2 25
9.7%
28.0%
Q1 25
7.6%
27.7%
Q4 24
-16.7%
27.9%
Q3 24
11.6%
28.4%
Q2 24
14.8%
29.9%
Net Margin
CRL
CRL
SNA
SNA
Q1 26
-1.5%
Q4 25
-27.8%
21.3%
Q3 25
5.4%
22.5%
Q2 25
5.1%
21.4%
Q1 25
2.6%
21.2%
Q4 24
-21.4%
21.7%
Q3 24
6.9%
22.0%
Q2 24
9.2%
23.1%
EPS (diluted)
CRL
CRL
SNA
SNA
Q1 26
$-0.30
Q4 25
$-5.57
$4.94
Q3 25
$1.10
$5.02
Q2 25
$1.06
$4.72
Q1 25
$0.50
$4.51
Q4 24
$-4.17
$4.83
Q3 24
$1.33
$4.70
Q2 24
$1.74
$5.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRL
CRL
SNA
SNA
Cash + ST InvestmentsLiquidity on hand
$191.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
Total Assets
$7.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRL
CRL
SNA
SNA
Q1 26
$191.8M
Q4 25
$213.8M
Q3 25
$207.1M
$1.5B
Q2 25
$182.8M
$1.5B
Q1 25
$229.4M
$1.4B
Q4 24
$194.6M
$1.4B
Q3 24
$210.2M
$1.3B
Q2 24
$179.2M
$1.2B
Total Debt
CRL
CRL
SNA
SNA
Q1 26
Q4 25
$2.1B
Q3 25
$2.2B
$1.2B
Q2 25
$2.3B
$1.2B
Q1 25
$2.5B
Q4 24
$2.2B
$1.2B
Q3 24
$2.3B
Q2 24
$2.4B
Stockholders' Equity
CRL
CRL
SNA
SNA
Q1 26
$2.9B
Q4 25
$3.2B
Q3 25
$3.4B
$5.8B
Q2 25
$3.4B
$5.7B
Q1 25
$3.2B
$5.5B
Q4 24
$3.5B
$5.4B
Q3 24
$3.8B
$5.5B
Q2 24
$3.7B
$5.3B
Total Assets
CRL
CRL
SNA
SNA
Q1 26
$7.7B
Q4 25
$7.1B
Q3 25
$7.5B
$8.4B
Q2 25
$7.6B
$8.2B
Q1 25
$7.6B
$8.1B
Q4 24
$7.5B
$7.9B
Q3 24
$8.0B
$8.0B
Q2 24
$7.9B
$7.8B
Debt / Equity
CRL
CRL
SNA
SNA
Q1 26
Q4 25
0.68×
Q3 25
0.64×
0.21×
Q2 25
0.70×
0.21×
Q1 25
0.79×
Q4 24
0.65×
0.22×
Q3 24
0.62×
Q2 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRL
CRL
SNA
SNA
Operating Cash FlowLast quarter
$41.1M
$268.1M
Free Cash FlowOCF − Capex
$254.6M
FCF MarginFCF / Revenue
20.8%
Capex IntensityCapex / Revenue
5.6%
1.1%
Cash ConversionOCF / Net Profit
1.03×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRL
CRL
SNA
SNA
Q1 26
$41.1M
Q4 25
$147.5M
$268.1M
Q3 25
$213.8M
$277.9M
Q2 25
$204.6M
$237.2M
Q1 25
$171.7M
$298.5M
Q4 24
$159.4M
$293.5M
Q3 24
$251.8M
$274.2M
Q2 24
$193.5M
$301.1M
Free Cash Flow
CRL
CRL
SNA
SNA
Q1 26
Q4 25
$58.6M
$254.6M
Q3 25
$178.2M
$258.0M
Q2 25
$169.3M
$217.5M
Q1 25
$112.4M
$275.6M
Q4 24
$83.7M
$275.4M
Q3 24
$213.1M
$253.8M
Q2 24
$154.0M
$277.9M
FCF Margin
CRL
CRL
SNA
SNA
Q1 26
Q4 25
5.9%
20.8%
Q3 25
17.7%
21.8%
Q2 25
16.4%
18.6%
Q1 25
11.4%
24.3%
Q4 24
8.4%
23.1%
Q3 24
21.1%
22.3%
Q2 24
15.0%
23.7%
Capex Intensity
CRL
CRL
SNA
SNA
Q1 26
5.6%
Q4 25
8.9%
1.1%
Q3 25
3.5%
1.7%
Q2 25
3.4%
1.7%
Q1 25
6.0%
2.0%
Q4 24
7.5%
1.5%
Q3 24
3.8%
1.8%
Q2 24
3.8%
2.0%
Cash Conversion
CRL
CRL
SNA
SNA
Q1 26
Q4 25
1.03×
Q3 25
3.93×
1.05×
Q2 25
3.91×
0.95×
Q1 25
6.74×
1.24×
Q4 24
1.14×
Q3 24
3.61×
1.09×
Q2 24
2.06×
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRL
CRL

Service revenue$798.2M80%
Product revenue$197.7M20%

SNA
SNA

Segment breakdown not available.

Related Comparisons